Early detection of rheumatoid arthritis using a smartphone tool
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This trial is testing a new way to catch rheumatoid arthritis early using a smartphone tool that records how your hands look and move. If you have early hand pain and a positive ACPA blood test, this study might help detect the disease sooner and guide earlier care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have pain or stiffness in the joints of your hands, like your knuckles or the middle joints of your fingers.
- These hand symptoms started less than a year ago.
- You have a blood test result showing a positive ACPA (a marker that may be linked to rheumatoid arthritis).
- You have not yet been treated with disease-modifying drugs for rheumatoid arthritis.
- You have not had surgery to replace or fuse hand joints, and you have access to a smartphone.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smartphone-based app that tracks hand symptoms to help detect rheumatoid arthritis flares and how well treatment is working. It aims to give patients and doctors an easier way to manage the disease between visits.
This study follows different groups of people—from those at high risk of developing rheumatoid arthritis to those recently diagnosed—to learn more about the disease. By joining, you help researchers understand who gets RA and why, which may lead to earlier detection and better care.
This study tests a new hand therapy program designed for people with rheumatoid arthritis. The program may help improve hand function and reduce discomfort.
This study tests a smart home blood collection platform for people with rheumatoid arthritis. It aims to make remote monitoring easier by allowing you to collect blood samples at home using a smartphone or tablet.
This study looks at people with very early rheumatoid arthritis to see if a simple blood test and an ultrasound of the neck can show early signs of heart artery damage. The goal is to catch heart disease risk sooner in RA patients.
This study tests an oral drug called AP1189 for people just diagnosed with active rheumatoid arthritis who haven't yet taken standard arthritis medicines. You may be able to take part if your disease is very active and you're ready to try a new treatment option.
Hear when a new Rheumatoid Arthritis (RA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.